Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · November 25, 2016

Mitogen-Activated Protein Kinase Inhibitors and Ocular Toxicity

JAMA Oncology

 

Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Oncology
Ocular Toxicity of Mitogen-Activated Protein Kinase Inhibitors
JAMA Oncol 2016 Nov 17;[EPub Ahead of Print], R MJ Purbrick, OA Osunkunle, DC Talbot, SM Downes

Further Reading